ArticleNPJ Parkinson's disease2025

Long-term oral glucocerebrosidase activator reduces soluble α-synuclein oligomer accumulation in Parkinsonian LRRK2 mutant mouse brain.

Zoe Yuen-Kiu Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.